Immunotherapie and Immunology news
Deleting the TFG-β receptor in NK cells overcame immune suppression and enabled anti-tumor activity in preclinical models. Preclinical research from The University of Texas MD Anderson Cancer Center finds that although glioblastoma stem cells (GSCs) can be targeted by natural killer (NK) cells, they are able to evade immune attack by releasing the TFG-β signaling […]
Read More »Stroke is an abrupt interruption of constant blood flow to the brain that causes loss of neurological function, there are 3 types: a blocked artery (ischemic stroke) or leaking or bursting of a blood vessel (hemorrhagic stroke) and transient ischemic attack (TIA also known as a mini stroke ). Different factors can lead to a stroke: high blood pressure, high […]
Read More »Researchers have designed a new bioink which allows small human-sized airways to be 3D-bioprinted with the help of patient cells for the first time. The 3D-printed constructs are biocompatible and support new blood vessel growth into the transplanted material. This is an important first step towards 3D-printing organs.
Read More »People with type 2 diabetes tend to have poorer muscle function than others. Now a research team has discovered that in type 2 diabetes, a specific gene is of great importance for the ability of muscle stem cells to create new mature muscle cells.
Read More »Researchers have designed an experimental drug that reversed key symptoms of Alzheimer’s disease in mice. The drug works by reinvigorating a cellular cleaning mechanism that gets rid of unwanted proteins by digesting and recycling them.
Read More »Abundant somatic cells of donor can be used Issues of histocompatibility with donor/recipient transplants can be avoided Very useful for drug development and developmental studies
Read More »Intravenous injection of bone marrow derived stem cells (MSCs) in patients with spinal cord injuries led to significant improvement in motor functions, researchers from Yale University and Japan report Feb. 18 in the Journal of Clinical Neurology and Neurosurgery.
Read More »There is an ongoing critical need to improve therapeutic strategies for COVID-19 pneumonia, particularly in the most severely affected patients. Adult mesenchymal stem cell (MSC) infusions have the potential to benefit critically ill patients with acute respiratory syndrome SARS-COV-2 infection, but clinical data supporting efficacy are lacking.
Read More »Most infected people will develop mild to moderate illness and recover without hospitalization having common symptoms such as dry cough, tiredness and light fever. Patients affected with a severe illness due to Sars-Cov-2 usually have difficulty breathing, chest pain or pressure, loss of speech or movement. Latest Stem Cells treatments showed promising results when medication […]
Read More »2021 has been a very challenging year for science where we never seen the medical community so divided. Our aim is to bring information about the amazing progress with stem cells therapy not only to recover from covid-19 but also in various fields such cancer therapy or organs regeneration. Feel free to subscribe and share […]
Read More »